Clinical effect and safety of methimazole or PTU combined with 131I in treatment of hyperthyroidism
10.7501/j.issn.1674-6376.2017.02.021
- VernacularTitle:甲巯咪唑联合131I治疗甲状腺功能亢进的疗效及安全性分析
- Author:
Huili XIONG
;
Qingyuan ZHOU
;
Xiaohong ZHAO
;
Liu YANG
- Keywords:
hyperthyroidism;
methimazole;
PTU;
131I
- From:
Drug Evaluation Research
2017;40(2):245-248
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the clinical effect and safety of methimazole combined with 131I in treatment of hyperthyroidism.Methods Patients (83 cases) with hyperthyroidism accepted in Xi'an Jiaotong University Affiliated San Er Ling Yi Hospital from June 2012 to June 2015 were selected and divided into observation group with 42 cases and control group with 41 cases.Patients in observation group were given methimazole combined with 131I,and patients in control group were given PTU combined with 131I.Then the clinical effect,thyroid gland serological indexes,adverse reations,and reoccurrence rates of two groups were observed and compared.Results The total clinical efficacy of observation group was 95.24％,which was obviously higher than 70.73％ of control group with statistically significance (P ＜ 0.05).TSH was getting higher after treatment of two groups,and T3,T4,FT3,FT4,TRAb,and TPOAb were getting lower after treatment of two groups.And TSH in the observation group was significantly higher than that in the control group,T3,T4,FT3,and FT4 were significantly lower than those in the control group (P ＜ 0.05).The adverse reaction rate of observation group (14.29％) was obviously lower than that of control group (46.34％) with statistically significance (P ＜ 0.05).The reoccurrence rate of observation group (4.76％) was obviously lower than that of control group (26.83％) with statistically significance(P ＜ 0.05).Conclusion Methimazole combined with 131I has good effect and safety in treatment of hyperthyroidism,which is worth of clinical application.
